Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

616 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Survival impact of occult liver metastasis and peritoneal dissemination compared with radiologically defined distant organ metastasis in pancreatic ductal adenocarcinoma.
Hashimoto D, Sakaguchi T, Satoi S, Yamamoto T, Yamaki S, Ishida M, Matsui Y, Shibata N, Boku S, Katsushima U, Ikeura T, Sekimoto M. Hashimoto D, et al. Among authors: sekimoto m. Pancreatology. 2023 Jan;23(1):73-81. doi: 10.1016/j.pan.2022.11.012. Epub 2022 Dec 1. Pancreatology. 2023. PMID: 36494309
The academic impact and value of an international online surgery lecture series.
Hashimoto D, Gulla A, Satoi S, Yamamoto T, Yamaki S, Matsui Y, Ohe C, Yamasaki M, Hamada M, Ikeura T, Shimatani M, Breugelmans R, Utkus A, Poskus T, Samuilis A, Miglinas M, Laurinavicius A, Tomoda K, Hendrixson V, Sekimoto M, Strupas K. Hashimoto D, et al. Among authors: sekimoto m. Surg Today. 2023 Sep;53(9):1100-1104. doi: 10.1007/s00595-023-02660-6. Epub 2023 Feb 15. Surg Today. 2023. PMID: 36790475 Free PMC article.
Impact of neoadjuvant therapy on gut microbiome in patients with resectable/borderline resectable pancreatic ductal adenocarcinoma.
Takaori A, Hashimoto D, Ikeura T, Ito T, Nakamaru K, Masuda M, Nakayama S, Yamaki S, Yamamoto T, Fujimoto K, Matsuo Y, Akagawa S, Ishida M, Yamaguchi K, Imoto S, Hirota K, Uematsu S, Satoi S, Sekimoto M, Naganuma M. Takaori A, et al. Among authors: sekimoto m. Pancreatology. 2023 Jun;23(4):367-376. doi: 10.1016/j.pan.2023.04.001. Epub 2023 Apr 5. Pancreatology. 2023. PMID: 37088586
Oncological role of surgical resection in patients with pancreatic ductal adenocarcinoma with liver-only synchronous metastases in a single-center retrospective study.
Satoi S, Yamamoto T, Hashimoto D, Yamaki S, Matsui Y, Ikeura T, Boku S, Shibata N, Tsybulskyi D, Sekimoto M. Satoi S, et al. Among authors: sekimoto m. J Gastrointest Oncol. 2023 Dec 31;14(6):2587-2599. doi: 10.21037/jgo-23-655. Epub 2023 Dec 27. J Gastrointest Oncol. 2023. PMID: 38196535 Free PMC article.
Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial.
Nakachi K, Ikeda M, Konishi M, Nomura S, Katayama H, Kataoka T, Todaka A, Yanagimoto H, Morinaga S, Kobayashi S, Shimada K, Takahashi Y, Nakagohri T, Gotoh K, Kamata K, Shimizu Y, Ueno M, Ishii H, Okusaka T, Furuse J; Hepatobiliary and Pancreatic Oncology Group of the Japan Clinical Oncology Group (JCOG-HBPOG). Nakachi K, et al. Lancet. 2023 Jan 21;401(10372):195-203. doi: 10.1016/S0140-6736(22)02038-4. Lancet. 2023. PMID: 36681415 Clinical Trial.
616 results